524703-BOM

Sandu Pharmaceuticals Ltd.

BSE: 524703

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

41.00+0.4 (+1.11%)

10 Jul, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap

39.61

P/E (TTM)

22.43

P/B

0.91

P/S (TTM)

0.57

EV/EBITDA

9.45

CAPE (5Y)

24.33

ROE (TTM)

4.12

ROCE (TTM)

5.37

ROA (TTM)

3.17

Avg 3Y ROE

3.84

Earnings 3Y CAGR

4.32

Sales 3Y CAGR

2.29

Sales 5Y CAGR

3.54

Debt/Equity

0.01

Consensus TP

Strong Buy %

Promoter Holding

37.79

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Sandu Pharmaceuticals Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Stock is reasonably valued and PE TTM is at a discount to industry median

PE TTM of 22.43 indicates that the stock is reasonably valued on a standalone basis. Discount to industry median P/E is decent at -27.72%

What is P/E Ratio?

Median: 31.03

Value 22.43

-215.443203.67

Moderate EPS growth and above median growth of industry

The company delivered moderate EPS growth of 14.14% for 12-month ended 31 Mar 2026 and the growth was 6.02 percentage points higher than median growth of industry

What is EPS growth (1Y)?

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.01 as on 31 Mar 2026 and Debt to Equity remained same in the last 1 year

What is Debt to Equity?

Consistently pays dividend

The company has not missed dividend payments once in the last 4 financial years

What is Dividend streak?

Company is net cash

The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet

What is Net Debt ?

Negative

Low but stable ROE

The company reported low ROE of 4.12% for 12-month ended 31 Mar 2026 and ROE improved marginally by 36 bps from 1 year ago

What is ROE (FY)?

Low but stable operating margin

The company reported low operating margin of 3.32% for 12-month ended 31 Mar 2026 and operating margin improved marginally by 20 bps from 1 year ago

What is Operating profit margin?

Low revenue growth and lower than median growth of industry

The company delivered moderate revenue growth of 4.08% for 12-month ended 31 Mar 2026 and the growth was 7.16 percentage points lower than median growth of industry

What is Sales growth (1Y)?

Median: 11.24

Value 4.08

-82.35114662

Neutral

Moderate dividend yield

The company has a moderate dividend yield of 1.95%

What is Dividend yield?

Financial Snapshot

See detailed analysis

Multi-year trends for Sandu Pharmaceuticals Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Sandu Pharmaceuticals Ltd. Shareholding Pattern

Quarterly breakdown of Sandu Pharmaceuticals Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Promoter	44.99	45.04	45.04	45.04	45.04	45.04	45.04	48.02	50.43	50.43	49.47	50.43	52.41	52.41	42.90	42.90	42.90	42.90	42.90	42.90	42.90	42.90	42.90	37.79	37.79
Indian Promoter	44.99	45.04	45.04	45.04	45.04	45.04	45.04	48.02	50.43	50.43	49.47	50.43	52.41	52.41	42.90	42.90	42.90	42.90	42.90	42.90	42.90	42.90	42.90	37.79	37.79
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Institution	55.00	54.95	54.95	54.95	54.95	54.95	54.95	51.97	49.56	49.56	50.52	49.56	47.58	47.58	57.09	57.09	57.09	57.09	57.09	57.09	57.09	57.09	57.09	62.21	62.21
Bodies Corporate	2.10	1.71	1.76	1.58	1.64	1.77	1.54	1.33	6.77	7.02	6.62	6.37	8.19	8.20	8.33	8.47	9.73	9.72	19.14	19.14	18.92	18.23	18.15	23.26	23.27
Others (incl. Retail) No. of shareholders	52.90 9,833	53.24 9,853	53.19 9,846	53.37 9,695	53.31 9,611	53.18 10,044	53.41 10,450	50.64 10,318	42.79 10,324	42.54 10,256	43.90 10,168	43.19 10,206	39.39 10,083	39.38 10,062	48.76 10,048	48.62 9,966	47.36 9,946	47.37 9,956	37.95 10,186	37.95 10,274	38.17 10,228	38.86 10,168	38.94 10,229	38.95 10,229	38.94 10,242

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Sandu Pharmaceuticals Ltd. shares as reported to NSE and BSE.

No bulk, block or insider trade data available.

Corporate Actions

History of Sandu Pharmaceuticals Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 0.80/share
Record date: 18th Sep 2025Ex-date: 18th Sep 2025
Announced on: 29th May 2025
Dividend₹ 0.80/share
Record date: 19th Sep 2024Ex-date: 19th Sep 2024
Announced on: 12th Aug 2024
Dividend₹ 0.75/share
Record date: 18th Sep 2023Ex-date: 18th Sep 2023
Announced on: 14th Aug 2023
Dividend₹ 0.75/share
Record date: 23rd Sep 2022Ex-date: 23rd Sep 2022
Announced on: 12th Aug 2022
Dividend₹ 0.50/share
Record date: 23rd Sep 2021Ex-date: 22nd Sep 2021
Announced on: 14th Aug 2021

Company Profile

Overview of Sandu Pharmaceuticals Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Sandu Pharmaceuticals Limited is an India-based company, which is mainly engaged in the business of manufacturing and trading of ayurvedic medicines under the brand name, SANDU. The Companys product category includes digestive health, immunity, muscle and bone health, respiratory health, wellness, a...

Key personnel

Mr. Vijay Kajrekar

Chief Financial Officer

Mrs. Pratika Prathamesh Mhambray

Compliance Officer, Company Secretary

Shri. Balram ViswanathanD

Non-Executive Independent Chairman of the Board

Smt. Jayshree Bhasker SanduD

Non-Executive Non-Independent Women Director

Shri. Shashank B. SanduD

Non-Executive Non-Independent Director

Shri. Ajit Rajaram KantakD

Additional Non-Executive Independent Director

Shri. Vijay KottapalliD

Additional Non-Executive Independent Director

Shri. Vijay KottapalliD

Additional Non-Executive Independent Director

Incorporated on

15 Nov 1985

Last Annual

31 Mar 2026

Last Interim

31 Mar 2026

No. of Employees

IPO date

26 Sep 1994

Free Float

33,19,826

Website

https://sandu.in/

Phone no.

+917777041566

Address

Sandu Nagar,D K Sandu Marg, Chembur, MUMBAI, 400071, India

Frequently Asked Questions

What is the current share price of Sandu Pharmaceuticals Ltd.?

The current share price of Sandu Pharmaceuticals Ltd. is ₹ 41.00 as of 10 Jul 2026.

What is the market capitalisation of Sandu Pharmaceuticals Ltd.?

The market capitalisation of Sandu Pharmaceuticals Ltd. stands at ₹ 39.61 Cr.

What is the PE ratio of Sandu Pharmaceuticals Ltd.?

The Price-to-Earnings (PE) ratio of Sandu Pharmaceuticals Ltd. is 22.43 as of the latest trailing twelve months data.

What is the ROE and ROCE of Sandu Pharmaceuticals Ltd.?

Sandu Pharmaceuticals Ltd. has a Return on Equity (ROE) of 4.12% and a Return on Capital Employed (ROCE) of 5.37% as per the latest financial reports.

What is the 52-week high and low of Sandu Pharmaceuticals Ltd.?

The 52-week high of Sandu Pharmaceuticals Ltd. is - and the 52-week low is -.

What is the dividend yield of Sandu Pharmaceuticals Ltd.?

The dividend yield of Sandu Pharmaceuticals Ltd. is 1.95% based on the current market price.

What is the FII and DII holding in Sandu Pharmaceuticals Ltd.?

Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.01% and retail/public investors hold 38.94% of Sandu Pharmaceuticals Ltd. shares.

What sector does Sandu Pharmaceuticals Ltd. belong to?

Sandu Pharmaceuticals Ltd. operates in the Healthcare sector.

What is the beta of Sandu Pharmaceuticals Ltd.?

The beta of Sandu Pharmaceuticals Ltd. is 0.63, indicating its price volatility relative to the broader market. Over the past 1 year, Sandu Pharmaceuticals Ltd. has delivered an absolute return of -18.02%.

What is the RSI of Sandu Pharmaceuticals Ltd.?

The 14-day Relative Strength Index (RSI) of Sandu Pharmaceuticals Ltd. is 46.66, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Sandu Pharmaceuticals Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Sandu Pharmaceuticals Ltd. Shareholding Pattern

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Company Profile

Corporate Actions